Arcutis Biotherapeutics
ARQT58
$13.93arrow_drop_up1.86%$0.25
High Growth
ARQT58
$13.93
arrow_drop_up1.86%Performance History
There's no data available for key stats
There's no data available for ratios/profitability stats
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
Period: Next 12 Months
•Analyst Ratings
••
Arcutis Biotherapeutics (ARQT)
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Todd Franklin Watanabe M.A.
- Headquarters
- Westlake Village
- Employees
- 268
- Exchange
- NASDAQ
Keep an eye on Arcutis Biotherapeutics
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.